*The following content is generated by AI and is for reference only.
Buparvaquone is a potent quinolone derivative widely recognized in veterinary medicine for its exceptional efficacy against tick infestations and protozoan parasites. Primarily utilized to treat Theileriosis, also known as East Coast Fever, this compound serves as a critical intervention for cattle and other livestock affected by *Theileria parva*. Its mechanism of action involves the disruption of mitochondrial electron transport within the parasite, effectively halting energy production and leading to rapid elimination of the pathogen. This unique mode of action distinguishes Buparvaquone from many other antiparasitic agents, offering high therapeutic success rates even in severe cases where early detection is crucial for animal survival.
The chemical identity of Buparvaquone is defined by the molecular formula C16H20O5 and it carries the CAS registry number 37980-43-3. Structurally, it belongs to the class of benzoquinones, characterized by a specific arrangement that allows for deep tissue penetration and sustained biological activity. Due to its lipophilic nature, the drug distributes efficiently throughout the body, reaching target tissues where parasites reside. It is commercially available in various formulations, including injectable solutions designed for subcutaneous or intramuscular administration, ensuring precise dosing and optimal bioavailability for treating infected herds.
Beyond its primary application in bovine theileriosis, research has explored its potential utility against other apicomplexan parasites, though regulatory approvals remain focused on tick-borne diseases. Safety profiles indicate that while generally well-tolerated in target species, dosage must be strictly adhered to prevent adverse reactions. Withdrawal periods are enforced to ensure meat and milk safety for human consumption, reflecting rigorous global food safety standards. As a cornerstone therapy in tropical and subtropical regions where tick-borne diseases pose significant economic threats to agriculture, Buparvaquone remains indispensable for maintaining herd health and productivity. Its continued use underscores the importance of targeted antiparasitic strategies in modern veterinary practice, safeguarding both animal welfare and global food security against devastating infectious outbreaks.